Johnson & Johnson Halts Sale Of Power Morcellators Following FDA Warning
This article was originally published in The Gray Sheet
The firm’s Ethicon unit is suspending its line of laparoscopic power morcellation systems for hysterectomy or myomectomy now that FDA has officially discouraged the procedure.
You may also be interested in...
Considerable value has been assigned to the companies developing coronavirus vaccines. Multiple suppliers and a met clinical need may erode much of that value after the pandemic.
Guidelines outline permitted practices and patient safeguards for both physicians and technology platforms.
Executives at Pfizer and Moderna expressed confidence in their US government partners for initial COVID-19 vaccine distribution and expect pediatric studies to begin before the end of the year. Regeneron will “do the right thing” in pricing its antibody cocktail.